Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.11851/11496
Title: | Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review | Authors: | Bor, Serhat Kalkan, İsmail H. Savarino, Edoardo Rao, Satish Tack, Jan Pasricha, Jay Cangemi, David |
Keywords: | efficacy gastrointestinal motility prokinetics safety Irritable-Bowel-Syndrome Placebo-Controlled Trial Severe Chronic Constipation Randomized Clinical-Trial Receptor Partial Agonist Gastrointestinal Contractile Activity Chronic Intestinal Pseudoobstruction Acute Colonic Pseudoobstruction Mitemcinal Fumarate Gm-611 Esophageal Acid Exposure |
Publisher: | Wiley | Abstract: | BackgroundProkinetics are a class of pharmacological drugs designed to improve gastrointestinal (GI) motility, either regionally or across the whole gut. Each drug has its merits and drawbacks, and based on current evidence as high-quality studies are limited, we have no clear recommendation on one class or other. However, there remains a large unmet need for both regionally selective and/or globally acting prokinetic drugs that work primarily intraluminally and are safe and without systemic side effects.PurposeHere, we describe the strengths and weaknesses of six classes of prokinetic drugs, including their pharmacokinetic properties, efficacy, safety and tolerability and potential indications. | URI: | https://doi.org/10.1111/nmo.14774 https://hdl.handle.net/20.500.11851/11496 |
ISSN: | 1350-1925 1365-2982 |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
Show full item record
CORE Recommender
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.